Clinical Trials Logo

Clinical Trial Summary

This is a retrospective study of our patient population implanted with the Medtronic's Leadless single-chamber ventricular pacemakers.


Clinical Trial Description

This protocol outlines the methods on the Micra Pacemaker. The Micra Transcatheter Pacemaker System is a miniaturized single chamber pacemaker system that is delivered via catheter through the femoral vein and is implanted directly inside the right ventricle of the heart. The Micra device eliminates the need for a device pocket and insertion of a pacing lead, thereby eliminating lead and pocket related complications associated with traditional pacing systems while providing similar pacing benefits. The US Food and Drug Administration (FDA) approved the Micra system on April 6, 2016, for the following conditions: - symptomatic paroxysmal or permanent high-grade atrioventricular block (AV) in the presence of atrial fibrillation (AF) - symptomatic paroxysmal or permanent high-grade AV block in the absence of AF, as an alternative to dual chamber pacing, when atrial lead placement is considered difficult, high risk, or not deemed necessary for effective therapy - symptomatic bradycardia-tachycardia syndrome or sinus node dysfunction (sinus bradycardia or sinus pauses), as an alternative to atrial or dual chamber pacing, when atrial lead placement is considered difficult, high risk, or not deemed necessary for effective therapy The FDA approved the Micra system on the basis of clinical trial evidence from the Micra Investigational Device Exemption (IDE) study (NCT02488681). On January 18, 2017, the Centers for Medicare and Medicaid Services (CMS) issued a final National Coverage Determination (NCD) on leadless pacemakers, providing for coverage with Coverage with Evidence Development (CED) of approved leadless pacemakers for approved indications (CAG-00448N). The NCD requires the research study conducted as part of CED to address the following research questions: 1. What are the peri-procedural and post-procedural complications of leadless pacemakers? 2. What are the long-term outcomes of leadless pacemakers? 3. What are the effects of patient characteristics (age, gender, comorbidities) on the use and health effects of leadless pacemakers? In addition, CMS outlined six evidentiary gaps in the final NCD for leadless pacemakers: 1. What are the peri-procedural and post-procedural complications, and long term outcomes of leadless pacemakers? 2. Are leadless pacemakers equivalent or superior to conventional pacemaker's in general clinical practice? 3. What are the infection rates, the long-term hemodynamic effects, and the rates of formation of thrombi? 4. What are the patient demographics and effects of patient characteristics (age, gender, comorbidities) on the use and health effects of leadless pacemakers? 5. What are the device-related issues (handling of end of battery life; effects of having multiple leadless pacemakers implanted; rate of device dislodgement; and the possibility of device extractions)? 6. How are operators and facility characteristics related to peri-procedural and post-procedural complications? ;


Study Design


Related Conditions & MeSH terms


NCT number NCT04051814
Study type Observational [Patient Registry]
Source Hoag Memorial Hospital Presbyterian
Contact Leila Andres, MS
Phone 949-764-4510
Email clinicalresearch@hoag.org
Status Recruiting
Phase
Start date July 31, 2019
Completion date May 15, 2025

See also
  Status Clinical Trial Phase
Recruiting NCT04870424 - Colchicine for Patients With Aortic Stenosis Undergoing Transcatheter Aortic Valve Replacement Phase 3
Completed NCT02548819 - University Hospital Cardiac Device MR Registry: The Safety of MR Imaging in Patients With Implanted Cardiac Devices N/A
Recruiting NCT03636230 - Remote Patient Management of CIEDs - Brady Devices N/A
Terminated NCT03859167 - Study of the Loss of AV Synchrony at Maximum Exercise
Completed NCT00832988 - CONFIRM - Comparison of in Office Interrogation Versus Remote Measurements
Completed NCT00294034 - VIBRANT Registry: Value of Information Based From Pacemaker Recordings and New Technologies N/A
Recruiting NCT05623527 - Acute Cerebrovascular Events Secondary to Patients Receiving Cardiac Electronic Implants
Completed NCT03847298 - Evaluation of Physical Fitness and Physical Activity Levels of Pediatric Arrhythmia Patients With Pacemaker
Completed NCT03843242 - Evaluation of Ventricular Pacing Suppression Algorithms in Dual Chamber Pacemaker N/A
Active, not recruiting NCT01138670 - Complications Following Pacemaker or Implantable Defibrillator Cardioverter (ICD) Implantation in Denmark N/A
Completed NCT00307073 - Adapta Pacing System Clinical Study N/A
Completed NCT04958369 - Ultrasound-guided Axillary Versus Conventional Cephalic Venous Access for Implantation of Cardiac Devices N/A
Completed NCT00631709 - REmote MOnitoring Transmission Evaluation of IPGs Phase 4
Completed NCT01459874 - Evaluation of an Organizational Model for Remote Monitoring of Pacemaker and Implantable Cardioverter Defibrillator Recipients N/A
Recruiting NCT06356207 - Syncope-Asystole Latency Time in Tilt Table Test: The SALT-TILT Study
Completed NCT03052829 - Physical Activity and Pacemaker Study N/A
Completed NCT00491777 - Correlation Research Study: IQ2, NcIQ and IQ101 Phase 1
Active, not recruiting NCT05361681 - EMI and CIED: Is High Power Charging of Battery Electric Car Safe? N/A
Recruiting NCT04201015 - Optimising Pacing for Contractility 2 Phase 2/Phase 3
Recruiting NCT03061747 - Multi-centre Observational Registry on Patients With Implantable Devices Remotely Monitored N/A